March 19, 2009 - The ZOLL Medical Corp. LifeVest Wearable Defibrillator has been prescribed for patients by physicians at all of the “Honor Roll” hospitals designated by U.S. News and World Report.
Patients at increased risk for sudden cardiac arrest (SCA) who wear the LifeVest allow their physicians time to decide how best to manage them long-term. The LifeVest reportedly has a 98 percent first shock success rate for treating patients with SCA, with no bystander intervention required.
The LifeVest features a unique, noninvasive technology that continuously monitors the patient’s heart. If a life-threatening heart rhythm is detected, the device alerts the patient —who may still be conscious—prior to delivering a shock. The device releases a conductive gel onto the therapy electrodes to protect the skin, and then delivers a shock to restore normal heart rhythm. The entire event usually occurs in less than a minute.
The LifeVest may be prescribed for patients following a heart attack, before or after bypass surgery or stent placement, as well as for those with cardiomyopathy or congestive heart failure that places them at particular risk. It may also be prescribed for patients whose comorbidities, including infections caused by placement of ICDs, prevent them undergoing immediate implant surgery for an ICD.
The 19 “Honor Roll” hospitals include such esteemed medical facilities as Johns Hopkins in Baltimore; the Mayo Clinic in Rochester, MN.; Ronald Reagan UCLA Medical Center in Los Angeles; Cleveland Clinic in Ohio; Massachusetts General Hospital in Boston; New York Presbyterian University Hospitals of Columbia and Cornell in New York; University of California, San Francisco Medical Center; Brigham and Women’s Hospital in Boston; Duke University Medical Center, Durham, NC.; Hospital of the University of Pennsylvania, Philadelphia; University of Washington Medical Center in Seattle; Barnes-Jewish Hospital/Washington University, St. Louis; University of Michigan Hospitals and Health Centers, Ann Arbor; University of Pittsburgh Medical Center; Vanderbilt University Medical Center, Nashville; Stanford Hospitals and Clinics, Stanford, CA.; University of Chicago Medical Center; Cedars-Sinai Medical Center, Los Angeles; and Yale-New Haven Hospital, New Haven, CT.
For more information, visit www.zoll.com
July 28, 2023 
